menu search

VIRX / Viracta Therapeutics to Present at the 33rd Annual Oppenheimer Healthcare Conference

Viracta Therapeutics to Present at the 33rd Annual Oppenheimer Healthcare Conference
SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced that Mark Rothera, its President and Chief Executive Officer, and Lisa Rojkjaer, M.D., its Chief Medical Officer, are scheduled to participate in a virtual fireside chat at the 33rd Annual Oppenheimer Healthcare Conference on Wednesday, March 15, 2023, at 12:00 p.m. ET. Read More
Posted: Mar 8 2023, 16:05
Author Name: GlobeNewsWire
Views: 102497

VIRX News  

Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference

By GlobeNewsWire
May 11, 2023

Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference

SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company focused on the treatment and preve more_horizontal

Viracta Therapeutics to Present at the 33rd Annual Oppenheimer Healthcare Conference

By GlobeNewsWire
March 8, 2023

Viracta Therapeutics to Present at the 33rd Annual Oppenheimer Healthcare Conference

SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company focused on the treatment and pre more_horizontal

Viracta Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

By PRNewsWire
April 7, 2022

Viracta Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

SAN DIEGO , April 7, 2022 /PRNewswire/ -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated maligna more_horizontal


Search within

Pages Search Results: